PMC:7558914 / 22432-22655 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"536","span":{"begin":86,"end":94},"obj":"Species"},{"id":"543","span":{"begin":38,"end":49},"obj":"Chemical"},{"id":"555","span":{"begin":100,"end":108},"obj":"Disease"},{"id":"556","span":{"begin":121,"end":130},"obj":"Disease"}],"attributes":[{"id":"A536","pred":"tao:has_database_id","subj":"536","obj":"Tax:9606"},{"id":"A543","pred":"tao:has_database_id","subj":"543","obj":"MESH:C502936"},{"id":"A555","pred":"tao:has_database_id","subj":"555","obj":"MESH:C000657245"},{"id":"A556","pred":"tao:has_database_id","subj":"556","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Several randomized clinical trials on tocilizumab, either alone or in combination, in patients with COVID-19 with severe pneumonia are underway, and its use was included in the Chinese national treatment guidelines [30,31]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T39","span":{"begin":121,"end":130},"obj":"Phenotype"}],"attributes":[{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Several randomized clinical trials on tocilizumab, either alone or in combination, in patients with COVID-19 with severe pneumonia are underway, and its use was included in the Chinese national treatment guidelines [30,31]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T145","span":{"begin":0,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Several randomized clinical trials on tocilizumab, either alone or in combination, in patients with COVID-19 with severe pneumonia are underway, and its use was included in the Chinese national treatment guidelines [30,31]."}